Archived Insight | May 26, 2020

University Business Article on Pandemic and Higher Education

In an article from University Business, Segal's Scott Nostaja gives insight on what issues leaders in higher ed may be grappling with as they steer their institutions into a post-pandemic future.

Read the article.

Questions about this story?

Get in touch with our media team for answers.

Key points from this article

The University Business article provides a high-level look at how institutions of higher education have grappled with the COVID-19 crisis, including:

The priorities of higher ed when the crisis first began unfolding
Why decision-makers have found it difficult to pivot to more long-term, strategic planning about the future
What these same leaders should be doing now to help secure their institution's future

Learn more from our insights

Female Nutritionist Holding Image Of Healthy Eating Plate

Health Coaching Enhances Well-Being and Productivity

Your organization can derive significant value from integrating health coaching into its existing health-management programs.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Lawyer And Business Person Discussing In The Office

Supreme Court Addresses Prohibited Transaction Lawsuits

As a result of the Supreme Court’s decision, it will be easier for participants to sue plans for everyday plan transactions with service providers.

Retirement, Compliance, Multiemployer Plans, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate

Read Full Insight

Pharmacist Taking Inventory With Digital Tablet

Executive Order Seeks to Lower Prescription Drug Prices

The order instructs federal departments to issue regulations or work with Congress to identify statutory changes necessary to address drug prices.

Health, Compliance, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate

Read Full Insight

Explore all COVID-19 information

We're regularly publishing information on the coronavirus as the situation changes.

Learn More

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.